Acetylcysteine In Diabetes (AID): A randomized study of acetylcysteine for the prevention of contrast nephropathy in diabetics

American Heart Journal

Volumn 151, Issue 5, 2006, Pages 1032.e9-1032.e12

  Coyle, Louis C ^a   Rodriguez, Antonio ^a   Jeschke, Robert E ^a   Simon Lee, Anabela ^a   Abbott, Kevin C ^a   Taylor, Allen J ^a  

^a WALTER REED ARMY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; CREATININE; CONTRAST MEDIUM; SODIUM CHLORIDE;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIABETES MELLITUS; DIABETIC NEPHROPATHY; FEMALE; HUMAN; HYDRATION; MAJOR CLINICAL STUDY; MALE; OPEN STUDY; PRIORITY JOURNAL; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; UREA NITROGEN BLOOD LEVEL; BLOOD; CHEMICALLY INDUCED DISORDER; DRUG ADMINISTRATION; INCIDENCE; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY DISEASE; MIDDLE AGED; ORAL DRUG ADMINISTRATION; TREATMENT FAILURE;

ACETYLCYSTEINE; ADMINISTRATION, ORAL; AGED; CONTRAST MEDIA; CORONARY ANGIOGRAPHY; CREATININE; DIABETES MELLITUS; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; INCIDENCE; INJECTIONS, INTRAVENOUS; KIDNEY DISEASES; MALE; MIDDLE AGED; SODIUM CHLORIDE; TREATMENT FAILURE;

EID: 33646114733     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2006.02.002     Document Type: Article

References (15)

1. Lautin E.M., Freeman N.J., Schoenfeld A.H., et al. Radiocontrast-associated renal dysfunction: incidence and risk factors. AJR Am J Roentgenol 157 (1991) 49-58
2. McCullough P.A., Wolyn R., Rocher LL., et al. Acute renal failure after coronary intervention: incidence, risk factors, and relationship to mortality. Am J Med 103 (1997) 368-375
3. Maeder M., Klein M., Fehr T., et al. Contrast nephropathy: review focusing on prevention. J Am Coll Cardiol 44 (2004) 1763-1771
4. Tepel M., van der G.M., Schwarzfeld C., et al. Prevention of radiographic-contrast-agent-induced reductions in renal function by acetylcysteine. [see comments]. N Engl J Med 343 (2000) 180-184
5. Alonso A., Lau J., Jaber B.L., et al. Prevention of radiocontrast nephropathy with N-acetylcysteine in patients with chronic kidney disease: a meta-analysis of randomized, controlled trials. Am J Kidney Dis 43 (2004) 1-9
6. Birck R., Krzossok S., Markowetz F., et al. Acetylcysteine for prevention of contrast nephropathy: meta-analysis. Lancet 362 (2003) 598-603
7. Isenbarger D.W., Kent S.M., and O'Malley P.G. Meta-analysis of randomized clinical trials on the usefulness of acetylcysteine for prevention of contrast nephropathy. Am J Cardiol 92 (2003) 1454-1458
8. Pannu N., Manns B., Lee H., et al. Systematic review of the impact of N-acetylcysteine on contrast nephropathy. Kidney Int 65 (2004) 1366-1374
9. Levey A.S., Bosch J.P., Lewis J.B., et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 130 (1999) 461-470
10. Hoffmann U., Fischereder M., Kruger B., et al. The value of N-acetylcysteine in the prevention of radiocontrast agent-induced nephropathy seems questionable. J Am Soc Nephrol 15 (2004) 407-410
11. Taylor A.J., Hotchkiss D., Morse R.W., et al. PREPARED: Preparation for Angiography in Renal Dysfunction: a randomized trial of inpatient vs outpatient hydration protocols for cardiac catheterization in mild-to-moderate renal dysfunction. Chest 114 (1998) 1570-1574
12. Bader B.D., Berger E.D., Heede M.B., et al. What is the best hydration regimen to prevent contrast media-induced nephrotoxicity?. Clin Nephrol 62 (2004) 1-7
13. Baker C.S., Wragg A., Kumar S., et al. A rapid protocol for the prevention of contrast-induced renal dysfunction: the RAPPID study. J Am Coll Cardiol 41 (2003) 2114-2118
14. Merten G.J., Burgess W.P., Gray L.V., et al. Prevention of contrast-induced nephropathy with sodium bicarbonate: a randomized controlled trial. JAMA 291 (2004) 2328-2334
15. Spargias K., Alexopoulos E., Kyrzopoulos S., et al. Ascorbic acid prevents contrast-mediated nephropathy in patients with renal dysfunction undergoing coronary angiography or intervention. Circulation 110 (2004) 2837-2842